Capsule for treating rhinitis

A technology for capsules and rhinitis, applied in the field of medicine for treating rhinitis, can solve the problems of low efficiency of the treatment method for rhinitis, and achieve the effects of exact curative effect and high cure rate

Inactive Publication Date: 2008-11-05
赵军海
View PDF0 Cites 8 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] In order to solve the problem of low effective rate of existing rhi

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0021] Embodiment 1: Biyan Capsules, get the raw material drug (100 grams per part) of the following weight ratio: 6 parts of Magnolia magnolia, 10 parts of Fructus Xanthium, 10 parts of Rhizoma Chuanxiong, 6 parts of Angelica dahurica, 6 parts of Schizonepeta, 10 parts of Fangfeng, Bupleuri 15 parts, Huang Ling 20 parts, Asarum 10 parts, Bellflower 9 parts, Mint 10 parts, Licorice 10 parts, Astragalus 15 parts, Angelica 15 parts, Metronidazole 10 parts, vitamin B11 parts, chlorpheniramine maleate 0.2 parts, 0.125 parts of prednisone acetate.

[0022] Above-mentioned medicine adopts traditional processing method, grinds traditional Chinese medicine into powder with pulverizer, mixes with western medicine powder, packs into capsule, and each grain weighs 1.5 grams.

Embodiment 2

[0023] Embodiment 2: Biyan Capsules, get the raw material drug (every part 100 grams) of following weight ratio: 8 parts of Magnolia Magnolia, 6 parts of Fructus Xanthii, 5 parts of Rhizoma Chuanxiong, 8 parts of Angelica dahurica, 8 parts of Schizonepeta, 6 parts of Fangfeng, Bupleuri 20 parts, 10 parts of Huang Ling, 7 parts of Asarum, 20 parts of bellflower, 6 parts of mint, 8 parts of licorice, 20 parts of astragalus, 30 parts of angelica, 15 parts of metronidazole, 11.5 parts of vitamin B1, chlorobenzene maleate Namin 0.1 part, prednisone acetate 0.2 part.

[0024] Above-mentioned medicine adopts traditional processing method, grinds traditional Chinese medicine into powder with pulverizer, mixes with western medicine powder, packs into capsule, and each grain weighs 1.5 grams.

Embodiment 3

[0025] Embodiment 3: Biyan Capsules, get the raw material drug (100 grams per part) of the following weight ratio: 10 parts of Magnolia Magnoliae, 8 parts of Fructus Xanthium, 7 parts of Rhizoma Chuanxiong, 10 parts of Angelica dahurica, 9 parts of Schizonepeta, 8 parts of Fangfeng, Bupleuri 17 parts, 15 parts of Huang Ling, 8 parts of Asarum, 16 parts of platycodon, 8 parts of mint, 9 parts of licorice, 25 parts of astragalus, 26 parts of angelica, 20 parts of metronidazole, 12 parts of vitamin B, chlorpheniramine maleate 0.15 parts, 0.25 parts of prednisone acetate.

[0026] Above-mentioned medicine adopts traditional processing method, grinds traditional Chinese medicine into powder with pulverizer, mixes with western medicine powder, packs into capsule, and each grain weighs 1.5 grams.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention pertains to the technical field of drugs for treatment for rhinitis, which can solve the problem of low effective rate of the existing treatment method of rhinitis. A rhinitis capsule is prepared by the following pharmaceutical raw materials: biond magnolia flower, siberian cocklour fruit, Szechuan lovage rhizome, dahurian angelica root, fineleaf schizonepeta herb, divaricate saposhnikovia root, Chinese thorowax root, baicalin, manchurian wildginger, platycodon root, peppermint, liquoric root, membranous milkvetch root, Chinese angelica, metronidazole, vitamin B1, chlorpheniramine maleate and prednisone acetate. The drug of the invention effectively combines the traditional Chinese medicine and the western medicine and learns from each other to offset the weaknesses; the clinical applications show that the efficacy is exact and the cure rate is high.

Description

technical field [0001] The invention belongs to the technical field of drugs for treating rhinitis. Background technique [0002] Rhinitis is an inconspicuous disease, but it is a persistent disease that plagues doctors and patients all over the world. The main clinical manifestations of chronic rhinitis are: headache, dizziness, sore throat, nasal congestion, sticky secretions, nasal itching, and runny nose. Rhinitis usually persists for a long time, mainly due to the following reasons: 1. The recurrence rate is high; 2. The cure rate is low; 3. The drug price is high and the course of disease is long. The traditional rhinitis treatment method is a single drug, or anti-inflammatory, clearing the lung, resuscitating, which only relieves the symptoms temporarily, but can not be cured completely; The patient fell into extreme worry, sadness, and even aggravated the condition. Contents of the invention [0003] In order to solve the problem of low effective rate of the exi...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K36/575A61K9/48A61P11/02A61K31/51A61K31/4164A61K31/4402A61K31/57
Inventor 赵军海
Owner 赵军海
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap